Cybin Inc. (NEO:CYBN)
Canada · Delayed Price · Currency is CAD 8.71
+0.11 (1.28%)
Nov 28, 2025, 3:03 PM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
430.86M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 687.61K | - | - |
| Jul 31, 2020 | - | - | - |
| Mar 31, 2020 | - | - | - |
| Jul 31, 2019 | - | - | - |
| Jul 31, 2018 | - | - | - |
| Jul 31, 2017 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |
Cybin News
- 8 days ago - Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges - GuruFocus
- 8 days ago - Q2 2026 Cybin Inc Earnings Call Transcript - GuruFocus
- 8 days ago - Cybin (CYBN) Analyst Rating Update: Canaccord Genuity Lowers PT to $45 | CYBN Stock News - GuruFocus
- 15 days ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Cybin (CYBN) Bolsters Financial Position to Advance Clinical Trials - GuruFocus
- 15 days ago - Cybin (CYBN) Reports Narrowed Q2 Net Loss - GuruFocus
- 15 days ago - Cybin reports Q2 results - Seeking Alpha
- 15 days ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire